Referencias

1. Calabrese EJ. Muller’s Nobel lecture on dose-response for ionizing radiation: ideology or science? Arch Toxicol 2011; 85:1495-8.
2. Tubiana M, Leinendegen LE, Yang C, Kaminski JM. The Linear No-Threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 2009; 251:13–22.
3. Calabrese EJ, Baldwin LA. Hormesis: The dose-response revolution. Annu Rev Pharmacol Toxicol 2003; 43:175-97.
4. Doss M. Shifting the paradigm in radiation safety. Dose Response 2012; 10:562–83.
5. Marcus CS. Time to reject the linear - no threshold hypothesis and accept thresholds and hormesis: A petition to the U.S. Nuclear Regulatory Commission. Clin Nucl Med 2015; 40:617–9.
6. Muckerheide J. Apply radiation health effects data to contradict and overturn radiation protection policies and rules. Proceedings of ICONE 8 (8th International Conference on Nuclear Engineering) April 2-6, 2000, Baltimore, MD.
7. Cutler, JM. Remedy for radiation fear---discard the politicized science. Dose Response 2014; 12:170-84.
8. Alderson P, Langhorst S, Palestro C, et al. Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nuclear Regulatory Commission (NRC). Report on the Hormesis / Linear No-Threshold Petitions. 14/10/2015.
9. NCRP Report No. 136: Evaluation of the Linear-Nonthreshold Dose-Response Model for Ionizing Radiation. 2001. NCRP, Bethesda, MD.
10. Jaworowski Z, Waligorski M. Problems of U.S. policy on radiation protection. EIR Science and Technology, 16 May 2003, pp. 18-26.
11. Calabrese EJ. The genetics panel of the NAS BEAR I Committee (1956): Epistolary evidence suggests self-interest may have prompted an exaggeration of radiation risks that led to the adoption of the LNT cancer risk assessment model. Arch Toxicol 2014; 88:1631-4.
12. Calabrese EJ. An abuse of risk assessment: how regulatory agencies improperly adopted LNT for cancer risk assessment. Arch Toxicol 2015; 89:647-8.
13. Calabrese EJ. Cancer risk assessment foundation unraveling: New historical evidence reveals that the U.S. National Academy of Sciences (US NAS), Biological Effects of Atomic Radiation (BEAR) Committee Genetics Panel falsified the research record to promote acceptance of the LNT. Arch Toxicol 2015; 89:649-50.
14. Ozasa K, Shimizu Y, Suyama A et al. Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: An overview of cancer and noncancerous diseases. Radiat Res 2012; 177:229-43.
15. Cardis E, Vrijheid M, Blettner M et al. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Radiat Res 2007; 167:396-416.
16. CNSC, Verifying Canadian nuclear energy worker radiation risk: a reanalysis of cancer mortality in Canadian nuclear energy workers (1957-1994): Summary report. Minister of Public Works and Government Services Canada. Catalogue number CC17265/2011E-PDF. ISBN 978-1-100-17760-1. Canadian Nuclear Safety Commission; 2011.
17. Li CY, Sung FC. A review of the healthy worker effect in occupational epidemiology. Occup Med 1999; 49:225-9.
18. Muirhead CR, O'Hagan JA, Haylock RGE et al. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer 2009; 100:206–12.
19. Marcus CS, Stabin MG, Siegel JA. The “healthy worker” effect could be backwards! Health Phys News, p.14, April 2011.
20. Wallis C. Never too old for chemo. Sci Am 2014; 311:34-36.
21. Cuttler JM, Pollycove M. Can cancer be treated with low doses of radiation? J Am Physicians and Surgeons 2003; 8:108-11.
22. Miller AB, Howe GR, Sherman GJ et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989, 321:1285-9.
23. Rowland, R.E. Dose and damage in long term radium cases. In Cloutier, Roger J., Edwards, C. Lowell, and Snyder, Walter S., eds.: Medical Radionuclides: Radiation Dose and Effects. Proceedings of a symposium held at the Oak Ridge Associated Universities Dec. 8-11, 1969. CONF-691212, available from Clearinghouse for Federal Scientific and Technical Information, National Bureau of Standards, U.S. Dept. of Commerce, Springfield, VA 22151, pp 369-386, 1970.
24. Tompkins E. Late effects of radioiodine therapy. In Cloutier, Roger J., Edwards, C. Lowell, and Snyder, Walter S., eds.: Medical Radionuclides: Radiation Dose and Effects. Proceedings of a symposium held at the Oak Ridge Associated Universities Dec. 8-11, 1969. CONF-691212, available from Clearinghouse for Federal Scientific and Technical Information, National Bureau of Standards, U.S. Dept. of. Commerce, Springfield, VA 22151, pp 431-440, 1970.
25. Kostyuchenko VA, Krestinina LY. Long-term irradiation effects in the population evacuated from the East-Urals radioactive trace area. Sci Total Environ 1994; 142:119-125.
26. Hwang SL, Guo HR, Hsieh WA, et al. Cancer risks in a population with prolonged low dose-rate ɣ-radiation exposure in radiocontaminated buildings, 1983-2002. Int J Radiat Biol 2006; 82:849-58.
27. Cohen BL. Expected indoor 222Rn levels in counties with very high and very low lung cancer rates. Health Physics 1989; 57:897-907.
28. Cohen BL. Test of the linear-no threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Physics, 1995; 68:157-74.
29. Cohen BL.: Lung cancer rate vs. mean radon level in U.S. counties of various characteristics. Health Physics 1997; 72:114-9.
30. Cohen BL. The linear no-threshold theory of radiation carcinogenesis should be rejected. J Am Physicians and Surgeons 2008; 13:70-6.
31. Scott B. Residential radon appears to prevent lung cancer. Dose Response 2011; 9:444-64.
32. Becker K. Health effects of high radon environments in Central Europe: Another test for the LNT hypothesis? Nonlinearity Biol Toxicol Med 2003; 1:3-35.
33. Jaworowski Z. Observations on Chernobyl after 25 years of radiophobia. 21st Century Science and Technology, summer 2010, pp 30-45, 2010.
34. UNSCEAR 2000b. United Nations Publication Sales No. E.00.IX.4; ISBN 92-1142239-6.
35. Moosa M, Mazzaferri EL. Occult thyroid carcinoma. The Cancer Journal 1997; 10:180-88.
36. Tan GH, Gharib H. Thyroid incidentalomas: Management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997; 126:226-31.
37. Ron E, Lubin J, Schneider AB. Thyroid cancer incidence. Nature 1992; 360:113.
38. Jargin SV. Chernobyl-related cancer and precancerous lesions: incidence increase vs. late diagnostics. Dose Response 2014; 12:404-15.
39. Tang FR, Loke WK. Molecular mechanisms of low dose ionizing radiation-induced hormesis, adaptive responses, radioresistance, bystander effects, and genomic instability. Int J Radiat Biol 2015; 91:13-27.
40. Brooks AL, Dauer LT. Advances in radiation biology: effect on nuclear medicine. Sem Nucl Med 2014; 44:179-86.
41. Joint report no2, Académie Nationale de Médecine, Institut de France—Académie des Sciences: Dose-effect relationships and the estimation of the carcinogenic effects of low doses of ionizing radiation. Edition Nucleon (Paris 2005) ISBN 2-84332-018-6.
42. BEIR VII, Phase 2. National Academy of Sciences-National Research Council: Health risks from exposure to low levels of ionizing radiation. National Academic Press, 2006, Washington, DC.
43. Tubiana M, Aurengo A, Averbeck D, Masse R. Recent reports on the effect of low doses of ionizing radiation and its dose-effect relationship. Radiat Environ Biophys 2006; 44:245-51.
44. Nuclear Regulatory Commission: A Proposed Rule by the Nuclear Regulatory Commission on 06/23/2015. https://www.federalregister.gov/articles/2015/06/23/2015-15441/linear-no-threshold-model-and-standards-for-protection-against-radiation
45. Siegel J, Pennington C, Sacks B, Welsh J. The birth of illegitimate linear no-threshold model: An invalid paradigm for estimating risk following low-dose radiation exposure. Am J Clin Oncol 2018; 41:173-7.